Pardes Biosciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch PRDS and buy or sell other stocks, ETFs, and their options commission-free!About PRDS
Pardes Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing and commercializing novel therapeutics to treat and prevent viral diseases. It also focuses on developing novel drugs to solve pandemic-sized problems like the coronavirus disease.
CEOJames B. Tananbaum, MD, MBA
CEOJames B. Tananbaum, MD, MBA
Employees—
Employees—
HeadquartersCarlsbad, California
HeadquartersCarlsbad, California
Founded2020
Founded2020
Employees—
Employees—
PRDS Key Statistics
Market cap133.95M
Market cap133.95M
Price-Earnings ratio-1.36
Price-Earnings ratio-1.36
Dividend yield—
Dividend yield—
Average volume840.73K
Average volume840.73K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$3.41
52 Week high$3.41
52 Week low$0.75
52 Week low$0.75
Stock Snapshot
Pardes Biosciences(PRDS) stock is priced at $2.16, giving the company a market capitalization of 133.95M. It carries a P/E multiple of -1.36.
On 2025-12-09, Pardes Biosciences(PRDS) stock opened at —, reached a high of —, and a low of —.
The Pardes Biosciences(PRDS)'s current trading volume is 0, compared to an average daily volume of 840.73K.
During the past year, Pardes Biosciences(PRDS) stock moved between $0.75 at its lowest and $3.41 at its peak.
During the past year, Pardes Biosciences(PRDS) stock moved between $0.75 at its lowest and $3.41 at its peak.
People also own
Based on the portfolios of people who own PRDS. This list is generated using Robinhood data, and it’s not a recommendation.